Hong Kong Baptist University
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
HKBU develops Chinese medicine for ulcerative colitis approved by National Medical Products Administration for clinical trial 2024-09-04 15:13
HKBU research identifies potential of phosphocholine in counteracting PM2.5 toxicity in lung diseases 2024-08-27 13:28
Official Swiss delegation experiences new frontiers in art tech at HKBU 2024-07-11 13:34
HKBU-led research predicts humidity trends will result in widespread heat stress in China 2024-06-11 14:59
New Chinese medicine drug developed by HKBU for myofibrillar myopathy granted orphan drug designation by FDA 2024-01-10 16:50
1